TABLE 2.
Median survival time of patients classified according to subtypes of lung cancer and gender
| Gendera |
|||
|---|---|---|---|
| Tumour subtypes | Male | Female | All |
| NSCLC | 33.7 (30.8–36.6) | 74.1 (66.6–81.6) | 37.7 (35.7–39.6) |
| NSCLC adenocarcinoma | 33.7 (28.6–38.7) | 87.5 (75.3–99.6) | 37.7 (33.9–41.4) |
| NSCLC squamous cell | 39.7 (35.0–44.3) | 27.5 (22.8–32.3) | 39.7 (35.6–43.7) |
| NSCLC with brain metastasis | Not calculabled | 31.0 (25.6–36.5) | 31.1 (27.5–34.7) |
| SCLC | 13.2 (11.8–14.6) | 47.2 (35.6–58.7) | 16.7 (15.1–18.3) |
| All subtypes | 25.8 (24.2–27.5) | 74.1 (67.4–80.8) | 33.7 (31.9–35.5) |
NSCLC = nonsmall cell lung cancer; SCLC, small cell lung cancer.
a
The median survival times are expressed in months, and the 95% confidence interval is displayed in the brackets.
b
This value could not be calculated because the last survival probability was > 0.5.